Ravulizumab - Alexion AstraZeneca Rare Disease
At a glance
- Drug Originator Alexion Pharmaceuticals
- Drug Class Anti-inflammatories; Antithrombotics; Eye disorder therapies; Monoclonal antibodies; Urologics
- Mechanism of Action Complement C5 inhibitors
- USA Patent Applicants ALEXION PHARM
- USA Patents 7
- BLAs 1
- International Patents 62

Disclaimer